A Targeted Therapy Next in Line for Biomarker-based Cancer Drug Approval?
recent data suggest that there is another potential contender for a biomarker-based FDA approval: a targeted therapeutic called larotrectinib...
recent data suggest that there is another potential contender for a biomarker-based FDA approval: a targeted therapeutic called larotrectinib...
There is perhaps nothing more painful for parents than receiving a cancer diagnosis for their child. Childhood cancers are...
Today is National “Don’t Fry Day,” an initiative undertaken by the National Council on Skin Cancer Prevention to encourage...
A study published recently in the AACR’s journal Cancer Discovery addresses the burgeoning question of the utility of high-throughput...
As the American population grows ever more diverse, cancer researchers are discovering that digging deep into demographic information can...
The fact that there are differences in screening mammography recommendations highlights the need for additional research into the benefits...
A hot topic in the field of cancer immunotherapy is: How do some cancers that initially respond to immune...
A team of researchers from Australia has shown that an optical fiber-tip probe that can detect the pH of...
Liver cancer rates have been on the rise in the United States and have tripled in the last four...
Understanding the identity of the factors that increase risk for a particular type of cancer is vital for developing...